Ligustilide‐loaded liposome ameliorates mitochondrial impairments and improves cognitive function via the PKA/AKAP1 signaling pathway in a mouse model of Alzheimer's disease. Here, AKAP1 is linked to early-onset autosomal dominant Alzheimer disease.